URGNUroGen Pharma Ltd.
$36.82+105% 1Y
$36.82
$16.4252 weeks$50.29
Is the price fair?
What URGN's price assumes
UroGen Pharma Ltd. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 8.88× revenue.
8.88
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 9.30
EV / sales
Details›
- EV / EBIToperating margin −35%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 9.30
- Market capitalisation
- $1.68B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks